ABSTRACT
; however, few further studies were reported until much later. Antisera to whole rat placental extracts were ad¬ ministered to normal pregnant rats on days 11 and 12 of gestation (Seegal Se Loeb 1940 ). These workers found that the treatment produced résorption of 66 per cent of foetuses; however, equal or greater damage to pregnancy could be produced by injections of antisera to rat blood. Therefore, no conclusions could be reached on the basis of this study regarding specific action of the antibodies. Later, the same authors (Loeb et al. 1949 ) demonstrated that abortion was induced in 100 per cent of pregnant rats injected with antiserum to rat placenta together with deoxycorticosterone acetate. Although the antiserum used in these latter experiments was more effective in producing abortion, all treated rats showed renal hypertrophy and nephritis. Another report (Cohen Se Nedzel 1940) described the abortion-inducing action of antisera to guinea pig placenta when administered to guinea pigs. Although anti¬ bodies to several organs were present in the antisera, in vitro absorption re¬ moved non-placenta specific antibodies and five of six pregnant animals aborted after the administration of absorbed antiserum. Similar studies as above were conducted in mice (Koren et al. 1968 ). An antiserum raised to whole mouse placentae in rabbits was injected into pregnant mice on days 10-14 of gestation. Although nearly all mice aborted, kidney and liver damage was observed in treated animals and approximately 10 per cent died following immunization. A control group of animals receiving normal rabbit serum did not suffer total loss of pregnancies and renal lesions were not correlated to the disruption of pregnancy in the treated animals. These studies suggested that at least some of the abortions were produced by specific antibodies to placentae.
Another study using rabbit anti-mouse placenta serum in mice showed abortion and toxicity despite prior absorption of the antisera (Nemirovsky 1970) . However, in 1971 Behrman and co-workers reported studies of passive immunization of mice with rabbit anti-mouse placenta serum in which much less toxicity was observed (Kometani 8c Behrman 1971) . Antisera were absorbed repeatedly with normal mouse serum and toxicity levels were established prior to the antifertility studies. Abortion could be produced in all animals if sera were administered on day 11 or later in gestation. Fewer abortions were ob¬ served when immunizations were performed during early pregnancy. Evidence was presented to suggest that cytotoxic effects produced by antisera were com¬ plement dependent. Immunodiffusion tests of effective antisera indicated anti¬ bodies to at least four different placental proteins.
Perhaps the most carefully conducted study of the effects of passive im¬ munization in rodents using antisera to placental proteins was reported by Beer et al. (1972) . Rat placenta at 12-14 days of gestation were homogenized and partially fractionated by centrifugation. The resulting trophoblast cells were used to immunize rabbits and the antisera obtained were used to pas¬ sively immunize pregnant rats at 7-18 days of gestation. The unabsorbed sera produced abortion in 100 per cent of the animals but 2 of 12 rats died from this treatment. In the same study, rabbit anti-rat lymphocyte serum caused abortion in 25 per cent of the treated rats but 67 per cent of the animals died.
Subsequently, rabbit anti-rat placenta serum was absorbed with rat lympho¬ cytes; the toxicity of the antisera disappeared but its abortifacient activity was retained. Conversely, when the anti-rat placenta serum was absorbed with rat trophoblast tissue, the abortifacient activity was no longer present. Histological examination of uteri, decidua, ovaries, kidneys, lungs and livers of female rats aborted with absorbed anti placenta serum revealed no detectable damage. The abortion-inducing action of anti-rat placental antisera was not effective in disrupting pregnancy in hamsters or mice. No effects upon pregnancy in female rats were observed when antisera to rat trophoblast produced in male rats were used.
Studies have also been conducted using antibodies to purified placental proteins. El Tomi et al. (1971 ) demonstrated that abortion could be produced in rats by administering antisera to highly purified human placental lactogen (HPL) raised in rabbits. Antisera were shown to cross-react with rat LH and rat prolactin and the number of implantations were reduced in animals in-jected with antisera early in gestation. Animals treated later in gestation had normal implantation numbers but significant foetal résorption occurred. This study suggested that sera to HPL reacted with rat placental antigen(s) neces¬ sary for normal gestation. Whether such substance(s) had any functional similarity to placental lactogen was not apparent from this study.
A similar study to the above was reported the following year (Gusdon 1972 (Hodgen et al. 1973) . A relatively low cross-reaction of antisera to the beta subunit of HCG with human or baboon LH has also been observed (Stevens, unpublished) . In this latter study, a sheep antiserum prepared against the beta subunit of Fig. 1 . Induction of abortion in a pregnant baboon with sheep anti-beta HCG serum (Stevens, unpublished (Fig. 1) . This work clearly confirmed the classical concept that chorionic gonadotrophin is necessary for maintaining the steroid secretion from the primate corpus luteum of pregnancy.
In recent years, extensive efforts have been made to evaluate the effects upon reproduction of antisera to non-hormonal primate placental proteins. In an extension of earlier work using antisera to whole placental extracts, Behr¬ man and co-workers recently reported antifertility effects of antisera directed to specific placental proteins of rhesus and squirrel monkeys (Behrman et al. 1974) . These workers isolated a fraction from monkey placental extracts that reacted with antisera raised against whole placentae even following absorption with normal serum. Although no antisera were produced to this fraction, the antisera reacting to it produced abortions in 63-80 per cent of the rhesus and squirrel monkeys studied. While this report suggests that antibodies producing abortions may be specifically directed to a placental protein, the criteria of purity of the reacting fraction were not documented and an exhaustive charac¬ terization of the abortifacient antisera was not presented.
Two "placenta-specific" proteins have been isolated from human term pla¬ centae by Bohn (1972) . One of these proteins is present in large amounts in pregnancy sera (SPj) while the other is not (PP:->)· Antisera raised in rabbits to human SPi have been shown to react with extracts of placentae and preg¬ nancy sera from rhesus monkeys, Cynomolgus monkeys and baboons (Bohn, unpublished) , but not with pregnancy sera of rats and guinea pigs (Bohn 8c Ronneberger 1973). Antibodies to human SPi were effective in producing abortions in 8 of 10 Cynomolgus monkeys at 19-55 days of gestation following a single injection (Bohn, unpublished) . Thus it appears that antibodies to SPi will cross-react readily with antigens from primate placentae but not with placental proteins from animals of lower phylogenetic levels. Further studies are necessary to determine the specificity and mechanism of abortifacient action of antibodies to SPj.
Active immunization studies
Relatively few studies have been conducted employing active immunization techniques with homologous or heterologous antigens. Even fewer reports have appeared in which highly purified proteins were used to elicit antibody respon¬ ses. In 1966 Okunda 8c Groilman reported studies in which female rats were immunized with whole rat placental extracts. Although 8 of 12 immunized rats conceived following mating, only one rat had any living foetuses by day 20 of gestation. The antisera produced in these animals reacted strongly with kidney extracts, and upon examination all animals showed nephritis. Whether disruption of fertility in these animals was related to antibodies to placental proteins could not be ascertained. Similar procedures were used and similar results were obtained in another study, in which rabbits were immunized with total rabbit conceptus from the ninth day of gestation (Menge 1968) .
Another study employed the guinea pig as the species immunized with whole placental extracts (Paine 8c In yet another study, no effects on conception or gestation were observed when extracts of homologous placentae were injected into rabbits; however, the number of pregnancies was reduced by one-half if the injections of ex¬ tracts were followed by chronic administration of HCG (Goldzieher et al. 1970) . No effects upon conception or on the course of pregnancy were noted from injections of HCG alone in this study. Similarly, Glass Se Mroueh (1967) found that rabbits immunized with HCG readily became pregnant and ex¬ hibited normal gestation. Since none of the studies discussed above described effects of active im¬ munization with a highly purified protein to a homologous species, few data were available to suggest feasibility of using such methods as a means of human fertility control. The design of studies for potential human application of active immunization was plagued by two major problems. The first of these is that isoantigens are rarely antigenic and the second is the unacceptability of Freund's complete adjuvant for human use. In an attempt to circumvent these problems, Effects of immunization with hapten-coupled HCG upon FSH and LH levels in a postmenopausal woman (Stevens, unpublished) . Oct. Nov.
Aug. Fig. 3 . Effects of immunization with haptcn-coupled HCG upon FSH and LH levels in a premenopausal woman (Stevens, unpublished) .
8 of 10 women during the period of significantly elevated antibody levels. Antibodies were abundant for only 1-2 months (Fig. 2) . In the same study, 4 previously sterilized premenopausal women were similarly immunized and a higher level of antibodies was observed. Likewise, endogenous LH levels were reduced for a longer period of time (Fig. 3) . Subsequent detailed studies showed that these premenopausal women were anovulatory, but unfortunately, no con¬ trol studies were performed to determine their ovulatory status prior to the immunization.
In order to demonstrate the effectiveness of immunological procedures for disrupting hormonal levels in endocrinologically normal women, another study was conducted in which control data showed normal hormonal patterns prior to the start of immunization (Stevens Se Crystle 1973 Fig. 4 .
Four of these six subjects were studied during another cycle six months after the first immunization. Significantly elevated antibody levels were found in 3 of the 4 cycles. Midcycle LH peaks were absent in 3 of the 4 cycles but the progesterone patterns suggested that two of the cycles were ovulatory. Levels of serum oestrogens were generally reduced in all four cycles and one of those showed only slight elevation at midcycle (Fig. 5) (Ross et al. 1972 ).
Since the subunit preparations used were not completely pure, it was hoped that a "pure" beta subunit of HCG might elicit antibody response to HCG, but not to LH. Consequently, a highly purified preparation of the beta subunit of HCG was used to immunize sheep, rabbits and baboons (Stevens, unpublished Immunological reactivity does not necessarily mean that the antiserum would also neutralize the biological effects. The biological effectiveness has been tested in at least two or three systems, such as the ventral prostate assay and the production of pro¬ gesterone by isolated corpus luteum slices. The antiserum is able to neutralize the HCG-induced effects in these systems.
In short, the main differences between Dr. Stevens' approach and ours is that we are dealing with a chemically and immunochemically purified preparation of beta subunit of HCG with almost negligible or no reaction with LH, and then the complex that we are studying is the subunit of the hormone conjugated in discrete proportions with a proteinic carrier, a type of vaccine approved for human use, i. e., the tetanus toxoid, which I think is highly immunogenic and has desirable immunization properties. Stevens: I think (Fig. A) is represented by its amino acid structure on this slide (Fig. B) We plan now to prepare several different synthetic peptides, all representing part or parts of the C-terminal portion of the HCG beta subunit that is exclusive to the chemical structure of HCG. We further plan to conjugate these peptides with varying types of acceptable conjugates that could be used in humans, and then evaluate each of these types with varying vehicles (adjuvants) and time schedules to obtain the ideal method of immunization. When these experiments are completed, we will im¬ munize baboons and perform critical studies of safety and efficacy. Then, hopefully, we will get permission from our Ethics Committee to perform human trials.
